Biophytis Statistics
Total Valuation
Biophytis has a market cap or net worth of $3.58 million. The enterprise value is $6.08 million.
| Market Cap | 3.58M |
| Enterprise Value | 6.08M |
Important Dates
The next estimated earnings date is Tuesday, May 7, 2024, before market open.
| Earnings Date | May 7, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Biophytis has 368,861 shares outstanding. The number of shares has increased by 359.13% in one year.
| Shares Outstanding | 368,861 |
| Shares Change (YoY) | +359.13% |
| Shares Change (QoQ) | +65.80% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 0.05% |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.72
| Current Ratio | 0.72 |
| Quick Ratio | 0.72 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -9.43 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -100.30% |
| Return on Capital (ROIC) | -324.79% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$859,899 |
| Employee Count | 22 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -93.65% in the last 52 weeks. The beta is 1.05, so Biophytis's price volatility has been similar to the market average.
| Beta (1Y) | 1.05 |
| 52-Week Price Change | -93.65% |
| 50-Day Moving Average | 16.44 |
| 200-Day Moving Average | 35.77 |
| Relative Strength Index (RSI) | 34.74 |
| Average Volume (30 Days) | 8,958 |
Short Selling Information
| Short Interest | 102,322 |
| Short Previous Month | 42,847 |
| Short % of Shares Out | 27.74% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.59 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -15.37M |
| Pretax Income | -18.25M |
| Net Income | -18.92M |
| EBITDA | -15.64M |
| EBIT | -16.50M |
| Earnings Per Share (EPS) | -$128.65 |
Balance Sheet
The company has $6.36 million in cash and $8.87 million in debt, giving a net cash position of -$2.50 million or -$6.79 per share.
| Cash & Cash Equivalents | 6.36M |
| Total Debt | 8.87M |
| Net Cash | -2.50M |
| Net Cash Per Share | -$6.79 |
| Equity / Book Value | -4.14M |
| Book Value Per Share | -11.21 |
| Working Capital | -3.77M |
Cash Flow
In the last 12 months, operating cash flow was -$13.80 million and capital expenditures -$235,859, giving a free cash flow of -$14.04 million.
| Operating Cash Flow | -13.80M |
| Capital Expenditures | -235,859 |
| Free Cash Flow | -14.04M |
| FCF Per Share | -$103.39 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Biophytis does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -359.13% |
| Shareholder Yield | -359.13% |
| Earnings Yield | -528.56% |
| FCF Yield | -392.19% |
Analyst Forecast
The average price target for Biophytis is $15.00, which is 54.59% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $15.00 |
| Price Target Difference | 54.59% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on April 23, 2024. It was a reverse split with a ratio of 1:40.
| Last Split Date | Apr 23, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:40 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |